AtriCure (ATRC) shares were up 8% in recent Monday trading after the company said it expects higher revenue for Q4 and fiscal 2024 from a year earlier.
The company said it expects Q4 revenue of $124.3 million, up about 17% from a year earlier.
Analysts polled by FactSet expect $120.4 million.
The company also said it predicts a 2024 revenue of $465.3 million, up 17% from 2023.
Analysts surveyed by FactSet expect $461.4 million.
AtriCure expects 2025 revenue of $517 million to $527 million.
FactSet analysts expect $522.2 million.
Price: 33.91, Change: +2.50, Percent Change: +7.96
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。